Cosmic Crypto ClubCosmic Crypto Club
Home
Markets
Tools
Academy
Brokers
DiscordLaunch Hub
Cosmic Crypto Club

Free trading education, market data & a community of serious traders. Join thousands learning to trade Crypto, Forex & Stocks.

Markets

  • Market Overview
  • Cryptocurrencies
  • Stocks
  • Forex
  • Indices
  • Commodities
  • News

Tools & Software

  • All Tools
  • Calculators
  • Screener
  • Economic Calendar
  • Trading Journal
  • Trading Software

Academy

  • Academy Home
  • Strategies
  • Glossary
  • How-To Guides
  • DeFi Protocols
  • Tax Guides

Brokers & Company

  • All Brokers
  • Crypto Exchanges
  • Prop Firms
  • About Us
  • Contact
  • FAQ

© 2026 Cosmic Crypto Club. All rights reserved.

Terms of ServicePrivacy PolicyCookie PolicyAffiliate DisclosureRisk & Investment Disclaimer

The information on cosmiccrypto.club is provided for general information purposes only. It does not constitute legal, financial, or professional advice. Cosmiccrypto.club does not accept responsibility for any loss or damage arising from reliance on the site's content. Users should seek independent advice and information before making financial decisions. Trading cryptocurrencies, stocks, and other financial instruments involves substantial risk and may not be suitable for every investor.

Back to Stocks
EXEL
Rank #1142EXEL

Exelixis, Inc.

$44.16

-0.70% (Daily)

Market Cap

$11.84B

Revenue

$2.32B

Rank by MCap

#1142

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Stelios Papadopoulos Ph.D.

Headquarters

Alameda, CA

Employees

1,077

About Exelixis, Inc.

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyro...

Exelixis, Inc. Price Chart

Loading chart…

Community & Socials

Website

Explore Related

Browse ETFsExplore CryptocurrencyView All S&P 500 Stocks